Hagar
Non-invasive continuous glucose monitoring technology
Hagar has raised €10.0M across 1 funding round from 1 investor, most recently a Series B round in Aug 2021. Based in Tel Aviv, Israel; active in Healthtech. Data as of 28 Oct 2026.
Tel Aviv, Israelwww.hagartech.com ↗
Total raised
€10.0M
€9,966,777
Funding rounds
1
Investors
1
distinct backers
Active since
2021-08
latest 2021-08
Funding by year
EUR raised per yearHagar — funding by year — interactive chart.
Data table
| Hagar — funding by year | |
|---|---|
| 2021 | €10.0M |
Signals
High confidenceRaise-next likelihood9
base rate 48% for Series B
- ▼ Dormant (no round in 3+ cohort gaps)
- ▼ Low backer re-investment
Timing: dormant vs cohort gap · momentum unknown. Funding-only estimates, not predictions and not investment advice — see signals.
Funding rounds
1 round| Date | Stage | Amount | Investors | |
|---|---|---|---|---|
| 2021-08-12 | Series B | €10.0M | Columbia Pacific | View deal → |
Investors
1Related news
- Hagar Raises $11.7M in Series B Fundingfinsmes.com · 2021-08
Similar companies
same sector or country- Philips€2.6BNetherlands · Healthtech
- Isomorphic Labs€2.3BUK · Healthtech
- CMR Surgical€1.5BUK · Healthtech
- Roivant Sciences€1.1BSwitzerland · Healthtech
- Neko Health€924MSweden · Healthtech
- Trax€789MIsrael · Software
Global coverage: FundingData